BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23945277)

  • 1. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.
    Wedzicha JA; Brill SE; Allinson JP; Donaldson GC
    BMC Med; 2013 Aug; 11():181. PubMed ID: 23945277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
    McGarvey L; Lee AJ; Roberts J; Gruffydd-Jones K; McKnight E; Haughney J
    Respir Med; 2015 Feb; 109(2):228-37. PubMed ID: 25613107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
    Capozzolo A; Carratù P; Dragonieri S; Falcone VA; Quaranta VN; Liotino V; D'Alba G; Castellana G; Resta O
    Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients.
    Wu YK; Su WL; Yang MC; Chen SY; Wu CW; Lan CC
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2475-2485. PubMed ID: 34511892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in systemic adaptive immunity contribute to the 'frequent exacerbator' COPD phenotype.
    Geerdink JX; Simons SO; Pike R; Stauss HJ; Heijdra YF; Hurst JR
    Respir Res; 2016 Oct; 17(1):140. PubMed ID: 27793198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation.
    Blasi F; Neri L; Centanni S; Falcone F; Di Maria G
    COPD; 2017 Feb; 14(1):15-22. PubMed ID: 27824270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
    Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD?
    Acet Öztürk NA; Görek Dilektaşlı A; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Kunt Uzaslan E
    Tuberk Toraks; 2020 Sep; 68(3):252-259. PubMed ID: 33295723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter.
    Lin Y; Sang L; Wang J; Chen Y; Lai J; Zhu X; Yang Y; Zhang Z; Liu Y; Wen S; Zhang N; Zhao D
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2353-2364. PubMed ID: 37928768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes and Inflammatory Responses of the Frequent Exacerbator in Pulmonary Rehabilitation: A Prospective Cohort Study.
    Jenkins AR; Holden NS; Gibbons LP; Jones AW
    COPD; 2020 Jun; 17(3):253-260. PubMed ID: 32362176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.
    Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
    BMC Pulm Med; 2020 Apr; 20(1):103. PubMed ID: 32326924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of chronic obstructive pulmonary disease phenotypes. One center prospective study.
    Said A; Esmail M; Abdel Naiem E; Zaki Z; Raouf R
    Adv Respir Med; 2021; 89(4):369-377. PubMed ID: 34494240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
    Santibáñez M; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; García-Rivero JL
    PLoS One; 2016; 11(6):e0158727. PubMed ID: 27362765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in cardiovascular risk and health-related quality of life in COPD patients according to clinical phenotype.
    Montiel AM; Ruiz-Esteban P; Del Río AD; Valdivielso P; Chaparro MÁS; Olveira C
    Sci Rep; 2024 Apr; 14(1):9687. PubMed ID: 38678074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
    Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with the Non-Exacerbator Phenotype of Chronic Obstructive Pulmonary Disease.
    Bouhuis D; Giezeman M; Hasselgren M; Janson C; Kisiel MA; Lisspers K; Montgomery S; Nager A; Sandelowsky H; Ställberg B; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():483-492. PubMed ID: 37051115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.